SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-20-026739
Filing Date
2020-05-22
Accepted
2020-05-22 16:09:06
Documents
11
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A xene-10qa_20200331.htm 10-Q/A 89414
  Complete submission text file 0001564590-20-026739.txt   228184

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT xene-20200331.xml EX-101.INS 7816
3 XBRL TAXONOMY EXTENSION SCHEMA xene-20200331.xsd EX-101.SCH 5792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20200331_lab.xml EX-101.LAB 25390
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20200331_pre.xml EX-101.PRE 15247
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36687 | Film No.: 20905913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences